STOCK TITAN

Arbutus Biopharma: Whitefort reports about 1.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Arbutus Biopharma Corp (ABUS) common shares were reported as beneficially owned by Whitefort Capital Master Fund, LP, which directly held 2,451,033 shares as of September 30, 2026. Whitefort Capital GP, LLC, Whitefort Capital Management, LP, Whitefort Capital Management GP, LLC, and Co-Managing Partners David Salanic and Joseph Kaplan may each be deemed to beneficially own the same shares; the reporting persons disclaim beneficial ownership of shares they do not directly own.

The reporting persons listed shared voting and dispositive power over 2,451,033 shares and no sole voting or dispositive power. Each reported approximately 1.6% ownership, calculated using 153,275,907 shares expected to be outstanding following closing of ABUS's tender offer, which expired September 29, 2026.

Beneficially owned shares 2,451,033 shares Directly owned by Whitefort Capital Master Fund, LP as of September 30, 2026; other reporting persons may be deemed to beneficially own the same position.
Ownership percentage Approximately 1.6% Reported by each reporting person as of September 30, 2026.
Shares expected outstanding 153,275,907 shares Expected following closing of the tender offer, which expired September 29, 2026; used as the ownership-percentage basis.
beneficial ownership regulatory
"may be deemed to beneficially own 2,451,033 Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 2,451,033.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 2,451,033.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ABUS shares did Whitefort report owning?

Whitefort Capital Master Fund, LP directly beneficially owned 2,451,033 ABUS common shares as of September 30, 2026, approximately 1.6% of the class. Whitefort Capital GP, LLC, Whitefort Capital Management, LP, Whitefort Capital Management GP, LLC, and Co-Managing Partners David Salanic and Joseph Kaplan may each be deemed to beneficially own that same position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





03879J100

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Whitefort Capital Master Fund, LP
Signature:/s/ David Salanic
Name/Title:David Salanic, Co-Managing Member of Whitefort Capital GP, LLC, its General Partner
Date:11/16/2026
Signature:/s/ Joseph Kaplan
Name/Title:Joseph Kaplan, Co-Managing Member of Whitefort Capital GP, LLC, its General Partner
Date:11/16/2026
Whitefort Capital GP, LLC
Signature:/s/ David Salanic
Name/Title:David Salanic, Co-Managing Member
Date:11/16/2026
Signature:/s/ Joseph Kaplan
Name/Title:Joseph Kaplan, Co-Managing Member
Date:11/16/2026
Whitefort Capital Management, LP
Signature:/s/ David Salanic
Name/Title:David Salanic, Co-Managing Partner
Date:11/16/2026
Signature:/s/ Joseph Kaplan
Name/Title:Joseph Kaplan, Co-Managing Partner
Date:11/16/2026
Whitefort Capital Management GP, LLC
Signature:/s/ David Salanic
Name/Title:David Salanic, Co-Managing Member
Date:11/16/2026
Signature:/s/ Joseph Kaplan
Name/Title:Joseph Kaplan, Co-Managing Member
Date:11/16/2026
David Salanic
Signature:/s/ David Salanic
Name/Title:David Salanic
Date:11/16/2026
Joseph Kaplan
Signature:/s/ Joseph Kaplan
Name/Title:Joseph Kaplan
Date:11/16/2026

Keep reading